The heightened emphasis on global compliance in the medtech industry has reached such a fever pitch that compliance officers are now referring to themselves as the company’s “designated felon”. Joking aside, the issue has become one of the sector’s greatest concerns as companies struggle to understand whether they will be fined or sent to jail because they gave a pen to a doctor in Massachusetts or because they bought a $2 bagel during a surgeon’s training session but failed to disclose it, or because they made a donation to a charitable foundation in Poland that happened to be run by the director of the local hospital’s tender board...
Scrip Regulatory Affairs
Global Compliance: Nowhere Left to Hide
13 May 2010
Karen Finn
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
